Jason S. Fritz - Faculty Biosketch

Jason S. Fritz, MD, FCCP

Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

Co-Director, Penn Presbyterian Dyspnea Program

PennChart Governance Divisional Liaison, Penn Medicine

Director, Penn Medicine University City, Pulmonary Function Lab

3 5f

Department: Medicine

4 1 b

46 Contact information
40

Harron Lung Center
2a Pulmonary Vascular Disease Program
25 Penn Medicine University City
3e 3737 Market St., 10th Floor
Philadelphia, PA 19104

2e Office: 215-662-8766
32 Fax: 215-243-3625
24

4 3 3 3 2 4 b 1f

13 Education:
21 9 B.S. 2b (Biology with honors, cum laude) c
2c Bucknell University, 1999.
21 9 M.D. 15 (Medicine) c
3d Temple University School of Medicine, 2003.
c

3 3 21

1f Post-Graduate Training
24 7f Internal Medicine Residency, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 2003-2006.
24 c5 Pulmonary and Critical Care Fellowship, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Case Western Reserve University, Cleveland, OH, 2007-2010.
c

3 25

17 Certifications
28 5c American Board of Internal Medicine, Diplomate in Internal Medicine, 2006.
28 5c American Board of Internal Medicine, Diplomate in Pulmonary Disease, 2009.
28 61 American Board of Internal Medicine, Diplomate in Critical Care Medicine, 2010.
c

3 92 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

Description of Clinical Expertise

44 1. Pulmonary hypertension: Diagnosis & management
36 2. Consultative pulmonology & second opinions
6b 3. Cardiopulmonary exercise testing and the evaluation of unexplained dyspnea (shortness of breath)
62

Description of Other Expertise

70 Dr. Fritz co-directs the multidisciplinary Dyspnea Program at Penn Presbyterian Medical Center.
8
c7 The Pulmonary Hypertension/Pulmonary Vascular Disease Program at the University of Pennsylvania is accredited as a Center of Comprehensive Care by the Pulmonary Hypertension Association (PHA).
65

Description of Research Expertise

43 Pulmonary vascular disease: Therapeutics, outcomes
e 29

Selected Publications

180 Meservey A, Al-Naamani N, Minhas J, Fritz JS, Appleby D, Baudry G, Girerd N, Feng R, Kawut SM, Moutchia J: Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis. Eur Respir J 66(2): 2402400, August 2025.

16d McCarthy BE, Feng R, Torigian DA, Tong Y, Fritz JS, Minhas JK, Mazurek JA, Smith KA, Palevsky HI, Pugliese SC, Homer NZ, MacLean MR, Udupa JK, Al-Naamani N: Epicardial adipose tissue as an independent risk factor for mortality in pulmonary arterial hypertension. Chest 167(5): 1481, May 2025.

100 Al-Naamani N, Prakash M, Pugliese S, Fritz JS, Smith KA, Palevsky HI, Compher C: Nutrition and diet quality in pulmonary arterial hypertension. Ann Am Thorac Soc 22(3): 462, Mar 2025.

178 Minhas J, Moutchia J, Al-Naamani N, Mazurek JA, Holmes JH, Appleby D, Smith KA, Fritz JS, Pugliese SC, Palevsky HI, Kawut SM: Electrocardiographic abnormalities and their association with outcomes in randomized clinical trials of pulmonary arterial hypertension. Ann Am Thorac Soc 21(6): 858, June 2024.

141 Pan HM, McClelland RL, Moutchia J, Appleby DH, Fritz JS, Holmes JH, Minhas J, Palevsky HI, Urbanowicz RJ, Kawut SM, Al-Naamani N: Heterogeneity of treatment effects by risk in pulmonary arterial hypertension. Eur Respir J 62(1): 2300190, July 2023.

17a McCarthy BE, McClelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, Urbanowicz RJ, Holmes JH, Palevsky HI, Kawut SM, Al-Naamani N: BMI and treatment response in patients with pulmonary arterial hypertension: a meta-analysis. Chest 162(2): 436-447, Aug 2022.

139 Matura LA, Fargo JD, Boyle K, Fritz JS, Smith KA, Mazurek JA, Pinder D, Archer-Chicko CL, Palevsky HI, Pack AI, Sommers MS, Kawut SM: Symptom phenotypes in pulmonary arterial hypertension: the PAH "symptome" Pulm Circ 12: e12135, July 2022.

ca Min J, Appleby DH, McClelland RL, Minhas J, Holmes JH, Urbanowicz RJ, Pugliese SC, Mazurek JA, Smith KA, Fritz JS, Palevsky HI, Suh JM, Al-Naamani N, Kawut SM 2 ab : Secular and regional trends among pulmonary arterial hypertension clinical trial participants. Ann Am Thorac Soc 19(6): 952-961, Jun 2022.

110 Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N: Systemic arterial properties in pulmonary hypertension. Pulm Circ 11(4): 1-3, Dec 2021.

12f Herzig M, Khandhar S, Palevsky H, Fritz J, Mehta M, Matthai W: Intermediate-term outcomes for patients with submassive pulmonary embolism treated with catheter-directed thrombolysis. J Invasive Cardiol 33(12): E949-E953, Nov 2021.

2c

7 1d

2c back to top
26 Last updated: 11/11/2025
34 The Trustees of the University of Pennsylvania c